CDK12 and brain neoplasm: Nevertheless, additional studies are required to better dissect the contribution of CDK12/13 in different aspects of the physiopathology of human nervous system diseases and to pave the ground for pre-clinical and clinical studies aimed at counteracting CDK12/13 activity as therapeutic tool for brain tumours.